CIK 0001743881
- Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,676,804
- in 3 filings, $1.7M under 10b5-1 plans
Net −$1,676,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-15 | Ellis Andrea Director | Purchase | +12,000 | $8.39 | $101K | 12,000 |
| 2022-03-14 | Dachille Douglas A. Director | Purchase | +10,000 | $8.19 | $82K | 20,000 |
| 2022-02-28 | SCHELLER RICHARD H Director | Grant or award · Restricted Stock Units | +25,566 | 25,566 | ||
| 2022-02-28 | HOMCY CHARLES J Director | Grant or award · Restricted Stock Units | +30,078 | 30,078 | ||
| 2022-02-16 | Kumar Neil CEO and President | Option exercise | +7,524 | 4,730,328 | ||
| 2022-02-16 | Kumar Neil CEO and President | Shares withheld for taxes | −3,085 | $8.84 | $27K | 4,727,243 |
| 2022-02-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units | −5,130 | 46,164 | ||
| 2022-02-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units | −2,394 | 28,730 | ||
| 2022-02-16 | STEPHENSON BRIAN C See Remarks | Option exercise | +2,488 | 307,375 | ||
| 2022-02-16 | STEPHENSON BRIAN C See Remarks | Shares withheld for taxes | −1,020 | $8.84 | $9K | 306,355 |
| 2022-02-16 | STEPHENSON BRIAN C See Remarks | Option exercise · Restricted Stock Units | −1,710 | 15,388 | ||
| 2022-02-16 | STEPHENSON BRIAN C See Remarks | Option exercise · Restricted Stock Units | −778 | 9,337 | ||
| 2022-01-05 | Dachille Douglas A. Director | Purchase | +5,000 | $15.91 | $80K | 10,000 |
| 2022-01-04 | Dachille Douglas A. Director | Purchase | +5,000 | $16.82 | $84K | 5,000 |
| 2021-12-30 | Lo Andrew Director | Purchase | +1,500 | $14.30 | $21K | 48,099 |
| 2021-12-30 | DANIELS RONALD J Director | Purchase | +10,402 | $14.34 | $149K | 10,402 |
| 2021-12-29 | Valantine Hannah Director | Purchase | +1,752 | $14.24 | $25K | 3,294 |
| 2021-12-29 | SAUNDERS BRENT L Director | Purchase | +17,600 | $14.48 | $255K | 17,600 |
| 2021-12-29 | Lo Andrew Director | Purchase | +6,000 | $12.90 | $77K | 46,599 |
| 2021-12-29 | Valantine Hannah Director | Purchase | +1,764 | $14.23 | $25K | 1,764 |
Page 36 of 44 · 868 trades